CN108497099A - Fullerene be used to be prepared into the purposes of fullerene microcapsule powder - Google Patents

Fullerene be used to be prepared into the purposes of fullerene microcapsule powder Download PDF

Info

Publication number
CN108497099A
CN108497099A CN201810259287.8A CN201810259287A CN108497099A CN 108497099 A CN108497099 A CN 108497099A CN 201810259287 A CN201810259287 A CN 201810259287A CN 108497099 A CN108497099 A CN 108497099A
Authority
CN
China
Prior art keywords
oil
fullerene
prepared
microcapsule powder
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810259287.8A
Other languages
Chinese (zh)
Inventor
黎小青
黄佳梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen Fukuji Biological Technology Co Ltd
Original Assignee
Xiamen Fukuji Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen Fukuji Biological Technology Co Ltd filed Critical Xiamen Fukuji Biological Technology Co Ltd
Priority to CN201810259287.8A priority Critical patent/CN108497099A/en
Publication of CN108497099A publication Critical patent/CN108497099A/en
Priority to CN201811123023.6A priority patent/CN110301483A/en
Priority to CN201811365406.4A priority patent/CN109258931A/en
Priority to CN201811365697.7A priority patent/CN109258932A/en
Priority to CN201811365700.5A priority patent/CN109258934A/en
Priority to CN202210449776.6A priority patent/CN115024365A/en
Priority to CN201811365699.6A priority patent/CN109258933A/en
Priority to PCT/CN2018/118812 priority patent/WO2019184419A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/02Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by the production or working-up
    • A23D7/04Working-up
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish
    • Y02A40/818Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses the purposes that fullerene be used to be prepared into fullerene microcapsule powder, the fullerene microcapsule powder that is prepared, which has, improves oxidation resistance, and/or improves immunity, and/or can pre- anti-cancer, delay neurodegenerative disease, and/or the purposes relieved the effect of alcohol.It can be taken in a manner of food simultaneously, it is more flexible various in mouthfeel and absorption mode.It is made into microcapsule powder and is greatly improved its application field.

Description

Fullerene be used to be prepared into the purposes of fullerene microcapsule powder
Technical field
The present invention relates to the use that fullerene field more particularly to a kind of fullerene be used to be prepared into fullerene microcapsule powder On the way.
Background technology
Fullerene is a kind of Spectra of Carbon Clusters being made of 60 carbon atoms, is the allotrope of graphite, diamond.It can Affine free radical has extremely strong oxidation resistance.Fullerene is because having the bioactivity such as antiviral, anti-oxidant, antibacterial, at me Be widely used in daily life and social production, such as cosmetics, pharmaceutical carrier, medical diagnosis various fields.2011 French Fathi Moussa research groups are published in the article on Biomaterials and disclose their great discovery:By C60 It is distributed to feeding mouse after olive oil, it is found that C60 does not have chronic toxicity, the service life of mouse can be made to extend 90% or more. To in the research of these neurodegenerative diseases caused by the deposition of amyloid fiber such as senile dementia, parkinsonism , it was also found that fullerene can effectively prevent the formation of amyloid fiber.To the research of liver cancer, it was also found that pass through be injected intraperitoneally it is rich It strangles alkene soluble derivative with anticarcinogen CTX, cisplatin to compare, find after having injected fullerene derivate, tumour is big It is big to inhibit, and concentration increases effect and also promoted, in an amount of from CTX 1/500 when effect and CTX it is suitable;Richness is compared with cisplatin The effect for strangling ene derivative is better.
Microcapsules technology is a kind of technology that solid or liquid are coated with filmogen and to form fine particle.Grease micro-capsule Powder is to develop a kind of very fast raw-food material in recent years, the good characteristic with common grease, is capable of providing energy, improves Flavour of food products and mouthfeel;Unlike, microcapsule powder can overcome the application drawback of conventional grease, such as prevent certain unstable foods The oxidation of product supplementary material is gone bad.On storage stability, by grease little particle be embedded dosage form at film wrapped up, therefore have Have and is not easy rancid thermal stability.Fullerene is not soluble in water, limits its development and application.In fullerene utilization, mainly will Water-soluble derivative is made in fullerene, is such as hydrated fullerene, Fullerol, fullerene-vitamin C, metal fullerene etc.;Right The treatment of liver cancer, kidney, neurodegenerative disease etc. has outstanding behaviours.So it is preferably and flexible to be badly in need of exploitation fullerene Purposes.
Invention content
The purpose of the present invention is to provide the purposes that fullerene be used to be prepared into fullerene microcapsule powder.
To achieve the above object, the present invention provides the purposes that a kind of fullerene be used to be prepared into fullerene microcapsule powder.
Further, the fullerene includes C60 and its derivative, C70 and its derivative, fullerene metal derivative, richness Strangle alkene oil solution.
Further, the fullerene microcapsule powder contains fullerene, nutrition compounding oil, food emulsifier and wall material.
Further, the weight consumption of the fullerene is 1 ‰ -5 ‰.
Further, the weight consumption of the nutrition compounding oil is 50%-70%;
Optional, the dosage of the food emulsifier is the 4-6% of the fat weight content in nutrition compounding oil;It is preferred that , the dosage of food emulsifier is the 5% of fat weight content;
Optional, the wall material weight consumption is 29%-49%.
Further, the oil fatty acid ratio of the nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:Mostly not Saturated fatty acid is 1:(0.5~2):(0.5~2), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~ 2);
Preferably, the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:How unsaturated Aliphatic acid is 1:(0.5~1.5):(0.5~1.5), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~ 1.5);
It is furthermore preferred that the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:More insatiable hungers It is 1 with aliphatic acid:1:1, wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:1.
Further, nutrition compounding oil be linseed oil, safflower seed oil, Purple Perilla Seed Oil, camellia seed oil, sunflower oil, Soybean oil, olive oil, pumpkin seed oil, evening primrose oil, borage oil, hippophae rhamnoides fruit oil, Seabuckthorm Seed Oil, peony seed oil, walnut oil, text It is preced with fruit oil, Seabuckthorn Oil, fiery sesame oil, linoleic acid, leukotrienes, linoleic acid triglyceride, conjugated linoleic acid, conjugated linoleic acid glycerine three Two or more combinations in ester.
Further, the food emulsifier is the mixture of A or A and B;Wherein A is oligomeric maltose, maltodextrin, consolidates 1 kind in body corn syrup, oligofructose, resistant dextrin, skimmed milk power or 2 kinds;B is casein sodium, list, diglycerine fatty Acid esters, starch Sodium Octenyl Succinate, ascorbic acid, sodium ascorbate, gelatin, polydextrose, phosphatide, natural VE, three One kind in polyphosphate sodium, Arabic gum and ascorbyl palmitate;
Optional, the wall material is soybean protein isolate, xanthans, converted starch, gelatin, carboxymethyl cellulose, malt 2 kinds or 3 kinds or more in dextrin mix.
Further, the preparation method of the microcapsule powder is,
It is prepared by oil phase:Nutrition compounding oil is prepared by fatty acid proportion, nutrition compounding is dissolved into after then fullerene sterilizes In oil, at the oily compound of compounding;Food emulsifier is dissolved into the oily compound of compounding, oil phase is obtained;
It is prepared by water phase:Wall material is dissolved in hot water and obtains water phase;Preferably, the temperature of hot water is 60-80 DEG C;Wherein temperature Less than 60 DEG C dissolvings are incomplete, and temperature is easily destroyed active ingredient higher than 80 DEG C;
Mixing sterilizing:Gained water phase is mixed evenly with oil phase, is then sterilized;
Homogeneous, spraying, drying:Homogeneous sprays, is dried to obtain fullerene microcapsule powder.
Further, the microcapsule powder have improve oxidation resistance, and/or improve immunity, and/or can pre- anti-cancer, prolong Delay neurodegenerative disease, and/or the purposes relieved the effect of alcohol.
Fullerene can not be all dissolved in grease, and additive amount increases not directly proportional to solubility.If dissolving is special It is few, it is simple in technique, it is at low cost, but the microcapsule powder taken in will increase accordingly, the oil quantity taken in accordingly just will increase, Human nutriology's requirement is not met;If the amount of dissolving is high, complex process, technical difficulty is big, and the cost of fullerene can increase Very much.Applicant had found when the additive amount of fullerene of the present invention is 1 ‰ -5 ‰ by extremely hard and bitter labour, can be with It is dissolved with simple agitating mode;When additive amount is more than 5 ‰, stirring can not all dissolve, and undissolved fullerene will pass through Centrifugal treating comes out, and the bad cleaning of remaining fullerene.Simultaneously by the experiment in terms of its effect, finding fullerene intake Amount is 8mg/ days/people, so that it may to show significant antioxidant effect.
When the additive amount of nutrition compounding oil is less than 50%, contained nutritional ingredient grease is just few, poor taste;When When the additive amount of nutrition compounding oil is higher than 70%, grease is easy broken wall, and embedding effect is bad, can influence to brew, the micro-capsule of production Powder is easy caking, conglomeration.
Nutrition of the present invention compounding oil is linseed oil, safflower seed oil, Purple Perilla Seed Oil, camellia seed oil, sunflower oil, big Soya-bean oil, olive oil, pumpkin seed oil, evening primrose oil, borage oil, hippophae rhamnoides fruit oil, Seabuckthorm Seed Oil, peony seed oil, walnut oil, Wen Guan 2 in fruit oil, fiery sesame oil, linoleic acid, leukotrienes, linoleic acid triglyceride, conjugated linoleic acid, conjugated linoleic acid triglyceride etc. It plants or 3 kinds or more is compounded by fatty acid proportion.
Wall material is 2 kinds in soybean protein isolate, xanthans, converted starch, gelatin, carboxymethyl cellulose, maltodextrin Or 3 kinds or more mix.
The food emulsifier is the mixture of A or A and B;Wherein A is oligomeric maltose, maltodextrin, corn in solids 1 kind in syrup, oligofructose, resistant dextrin, skimmed milk power or 2 kinds;B be casein sodium, list, diglycerine fatty acid ester, Starch Sodium Octenyl Succinate, ascorbic acid, sodium ascorbate, polydextrose, phosphatide, natural VE, sodium tripolyphosphate, 2 kinds or 3 kinds or more in Arabic gum, ascorbyl palmitate mix.The dosage of food emulsifier is usually fat 5% or so of content, compound use can reach microcapsule powder stability height, and the laxity of good water solubility, microcapsule powder is good, is not easy to tie Block, conglomeration comparatively ideal effect.
It can be taken in a manner of food after microcapsule powder is made in fullerene, it is more flexible more in mouthfeel and absorption mode Sample.It is made into microcapsule powder and is greatly improved its application field.Fullerene microcapsule powder of the present invention uses raw-food material for packet Material is wrapped up in, the various nourishing beverage of instant edible, flavor is transformed into, can be short-term or be taken for a long time, there is anti-aging, inhibit The health-care efficacy of cancer has high promotional value.
Specific implementation mode
The embodiment of the present invention is described below in detail, the examples of the embodiments are intended to be used to explain the present invention, and cannot It is interpreted as limitation of the present invention.In the examples where no specific technique or condition is specified, according to described by document in the art Technology or condition or carried out according to product description.Reagents or instruments used without specified manufacturer is that can lead to Cross the conventional products of acquisition purchased in market.
A kind of fullerene be used to be prepared into the purposes of fullerene microcapsule powder.
Further, the fullerene includes C60 and its derivative, C70 and its derivative, fullerene metal derivative, richness Strangle alkene oil solution.
Further, the fullerene microcapsule powder contains fullerene, nutrition compounding oil, food emulsifier and wall material.
Further, the weight consumption of the fullerene is 1 ‰ -5 ‰.
Further, the weight consumption of the nutrition compounding oil is 50%-70%;
Optional, the dosage of the food emulsifier is the 4-6% of the fat weight content in nutrition compounding oil;It is preferred that , the dosage of food emulsifier is the 5% of fat weight content;
Optional, the wall material weight consumption is 29%-49%.
Further, the oil fatty acid ratio of the nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:Mostly not Saturated fatty acid is 1:(0.5~2):(0.5~2), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~ 2);
Preferably, the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:How unsaturated Aliphatic acid is 1:(0.5~1.5):(0.5~1.5), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~ 1.5);
It is furthermore preferred that the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:More insatiable hungers It is 1 with aliphatic acid:1:1, wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:1.
Further, nutrition compounding oil be linseed oil, safflower seed oil, Purple Perilla Seed Oil, camellia seed oil, sunflower oil, Soybean oil, olive oil, pumpkin seed oil, evening primrose oil, borage oil, hippophae rhamnoides fruit oil, Seabuckthorm Seed Oil, peony seed oil, walnut oil, text It is preced with fruit oil, Seabuckthorn Oil, fiery sesame oil, linoleic acid, leukotrienes, linoleic acid triglyceride, conjugated linoleic acid, conjugated linoleic acid glycerine three Two or more combinations in ester.
Further, the food emulsifier is the mixture of A or A and B;Wherein A is oligomeric maltose, maltodextrin, consolidates 1 kind in body corn syrup, oligofructose, resistant dextrin, skimmed milk power or 2 kinds;B is casein sodium, list, diglycerine fatty Acid esters, starch Sodium Octenyl Succinate, ascorbic acid, sodium ascorbate, gelatin, polydextrose, phosphatide, natural VE, three One kind in polyphosphate sodium, Arabic gum and ascorbyl palmitate;
Optional, the wall material is soybean protein isolate, xanthans, converted starch, gelatin, carboxymethyl cellulose, malt 2 kinds or 3 kinds or more in dextrin mix.
Further, the preparation method of the microcapsule powder is,
It is prepared by oil phase:Nutrition compounding oil is prepared by fatty acid proportion, nutrition compounding is dissolved into after then fullerene sterilizes In oil, at the oily compound of compounding;Food emulsifier is dissolved into the oily compound of compounding, oil phase is obtained;
It is prepared by water phase:Wall material is dissolved in hot water and obtains water phase;Preferably, the temperature of hot water is 60-80 DEG C;
Mixing sterilizing:Gained water phase is mixed evenly with oil phase, is then sterilized;
Homogeneous, spraying, drying:Homogeneous sprays, is dried to obtain fullerene microcapsule powder.
Further, the microcapsule powder have improve oxidation resistance, and/or improve immunity, and/or can pre- anti-cancer, prolong Delay neurodegenerative disease, and/or the purposes relieved the effect of alcohol.
Embodiment 1:The preparation of fullerene microcapsule powder
Raw material usage (weight percent %) table of 1 embodiment 1- of table
Sterile fullerene Emulsifier Nutrition compounding oil Wall material
Embodiment 1 1‰ 3.0% 50% 46.90%
Embodiment 2 5‰ 3.5% 70% 26.00%
Embodiment 3 2.5‰ 2.5% 50% 47.25%
Embodiment 4 3‰ 3.0% 60% 36.70%
The manufacture craft of fullerene microcapsule powder includes:
(1) it presses fatty acid proportion and prepares nutrition compounding oil;
(2) it is dissolved into after fullerene sterilizing in nutrition compounding oil, forms the oily compound of compounding;
(3) food emulsifier is dissolved into the oily compound of compounding, obtains oil phase;
(4) wall material is dissolved in 60-80 DEG C of hot water and obtains water phase;
(5) gained water phase is mixed evenly with oil phase, is then sterilized;
(6) homogeneous, spray, be dried to obtain fullerene microcapsule powder.
It is vitamin that the fullerene microcapsule powder being prepared measures its oxidation resistance by external beta carotene oxidizing process 125 times of C.
Embodiment 2:The preparation of fullerene microcapsule powder
Raw material:It is shown in Table 1.
Manufacture craft, with embodiment 1.The fullerene microcapsule powder being prepared is measured by external beta carotene oxidizing process Its oxidation resistance is ascorbic 125 times.
Embodiment 3:The preparation of fullerene microcapsule powder
Raw material:It is shown in Table 1.
Manufacture craft, with embodiment 1.The fullerene microcapsule powder being prepared is measured by external beta carotene oxidizing process Its oxidation resistance is ascorbic 125 times.
Embodiment 4:The preparation of fullerene microcapsule powder
Raw material:It is shown in Table 1.
Manufacture craft, with embodiment 1.The fullerene microcapsule powder being prepared is measured by external beta carotene oxidizing process Its oxidation resistance is ascorbic 125 times.
Embodiment 5:The effect experiment of the raising immunity of fullerene microcapsule powder
Powder or pressure is made in fullerene the microcapsule powder 5g, anthocyanidin 1g, vitamin C 500mg of any gained of embodiment 1-4 Tablet is made, long-term use has the function of improving immunity.
Embodiment 6:Fullerene microcapsule powder is used for the effect experiment of health care
The fullerene microcapsule powder 20g of any gained of embodiment 1-4.One people is once a day eaten in the form of directly brewing for a long time With, can pre- anti-cancer, delay neurodegenerative disease such as Parkinson, senile dementia etc..Patient reaction's fullerene microcapsule powder simultaneously More people is allowed to receive than simple fullerene olive oil in mouthfeel and edible way.
Embodiment 7:The disintoxicating product and compliance test result of the microcapsule powder containing fullerene are tested
Fullerene microcapsule powder 2g, pueraria lobata 1g, hoveniae semoveniae semen 1g, Poria cocos 0.25g, the honey 1g of any gained of embodiment 1-4, will Powder or solid particle is made in it, takes before drinking and is still drank after a night after drinking with alleviation, the symptom for vomiting of having a headache.
It relieves the effect of alcohol experiment:
Product Safety of the present invention measures:
Healthy clean type kunming mice 20 (weight 18-22g), half male and half female, random pair is taken to be divided into two groups, every group 10 Only, administration group:0.33ml/20gBW (10 times that are equivalent to people's dose) (computational methods:People's effective dose 5.25g (presses human body Weight 65Kg conversions), it is about 0.0165 to be converted into 10 multiple dose of 20g mouse;Disintoxicating product 0.5g is taken to be dissolved in 10ml water, 0.33ml contains Have 0.0165g, i.e. intragastric administration on mice aequum is 0.33ml/20g), control group:Give 0.33ml/20gBW normal salines. Two groups are continuously fed 7d, observe mouse growth state and adverse reaction and death condition.Put to death within 8th day mouse, naked eyes and mirror Lower each internal organs abnormal conditions of observation.Observation result is shown:Mouse does not occur adverse reaction, and each internal organs are also without exception under the microscope It was found that.
Preliminary experiment:
With reference to related document, with 0.26ml/20g, 0.28ml/20g, 0.30ml/20g, 0.32ml/20g, 0.34ml/ 20g, 0.36ml/20g wine solution (56 degree of Red Star strong, colourless liquor distilled from sorghum) carry out gavages to 6 groups of mouse respectively, every group 6.Observation makes mouse There is righting reflex loss and the required capacity for liquor without dead mouse.Experimental result such as table 2:Select gavage 0.30ml/20g wine solution Do subsequent experimental.
Influence table of the table 2 to the mouse alcoholism death rate
Group Total n Alcohol (ml/20g) Dead n (%) Survival n (%) Drunk n (%)
A 10 0.26 0 100 30
B 10 0.28 0 100 50
C 10 0.30 0 100 100
D 10 0.32 20 80 100
E 10 0.34 60 40 100
F 10 0.36 90 10 100
The influence of administration drunk to acute alcoholism mice time, the time of relieving the effect of alcohol and drunk rate:
Mouse is randomly divided into 4 groups:Model group (gavaging isometric(al) physiological saline), low dose group (gavage 0.1ml/20g), in Dosage group (gavage 0.2ml/20g), high dose (gavage 0.3ml/20g), every group 10.Each group mouse fasting 12h, disposably gives Medicine.Each group is using 15ml/kg (with preliminary data as foundation) 56 DEG C of Beijing Erguotou wine gavages of weight, observation note after 30min The mice drunk time (from the time regained consciousness to areflexia anyway) is recorded, the drunk rate in for 24 hours is calculated.Whether mice drunk, with Whether righting reflex disappears for standard:Mouse fills after drinking by it under, is gently put into mouse cage, if posture of the mouse under is protected Hold 30s or more, then it is assumed that righting reflex loss, it is as drunk.Mouse is observed and recorded to sober up the time (from righting reflex loss to clear The awake time), calculate the death rate in for 24 hours.As a result such as table 3-4:As can be seen that the present invention has good dispelling effects of alcohol.
The dose form of 3 different experiments group of table
Group Quantity Dosage (ml/20g) It is equivalent to human body amount (mg/kg)
Control group 20 0.1 -
Low dose group 20 0.04 150
Middle dose group 20 0.08 300
High dose group 20 0.1 450
10 points start gavage wine.
Note:Wherein control group administration be to ddH2O。
The result table of the different group gavages of table 4 after drinking
From table 3-4 it is found that low dose group, middle dose group, high dose group and contrast ratio, drunk duration are obviously shortened, and with The increase of dosage, duration reduces, illustrates to take the disintoxicating product containing microcapsule powder, has apparent rescue effect.
Although the embodiments of the present invention has been shown and described above, it is to be understood that above-described embodiment is example Property, it is not considered as limiting the invention, those skilled in the art are not departing from the principle of the present invention and objective In the case of can make changes, modifications, alterations, and variations to the above described embodiments within the scope of the invention.

Claims (10)

1. fullerene be used to be prepared into the purposes of fullerene microcapsule powder.
2. fullerene as described in claim 1 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the richness It includes C60 and its derivative, C70 and its derivative, fullerene metal derivative, fullerene oil solution to strangle alkene.
3. fullerene as described in claim 1 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the fowler Alkene microcapsule powder contains fullerene, nutrition compounding oil, food emulsifier and wall material.
4. fullerene as claimed in claim 3 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the fowler The weight consumption of alkene is 1 ‰ -5 ‰.
5. fullerene as claimed in claim 3 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the nutrition The weight consumption of compounding oil is 50%-70%;
Optional, the dosage of the food emulsifier is the 4-6% of the fat weight content in nutrition compounding oil;Preferably, it eats It is the 5% of fat weight content with the dosage of emulsifier;
Optional, the wall material weight consumption is 29%-49%.
6. fullerene as claimed in claim 3 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the nutrition The oil fatty acid ratio of compounding oil is saturated fatty acid:Monounsaturated fatty acids:Polyunsaturated fatty acid is 1:(0.5~2): (0.5~2), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~2);
Preferably, the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:Polyunsaturated fat Acid is 1:(0.5~1.5):(0.5~1.5), wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:(0.5~1.5);
It is furthermore preferred that the oil fatty acid ratio of nutrition compounding oil is saturated fatty acid:Monounsaturated fatty acids:How unsaturated fat Fat acid is 1:1:1, wherein polyunsaturated fatty acid Linoleic acid:Leukotrienes is 1:1.
7. fullerene as claimed in claim 3 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the nutrition Compounding oil be linseed oil, safflower seed oil, Purple Perilla Seed Oil, camellia seed oil, sunflower oil, soybean oil, olive oil, pumpkin seed oil, Evening primrose oil, borage oil, hippophae rhamnoides fruit oil, Seabuckthorm Seed Oil, peony seed oil, walnut oil, shinyleaf yellowhorn oil, Seabuckthorn Oil, fiery sesame oil, Asia Two or more combinations in oleic acid, leukotrienes, linoleic acid triglyceride, conjugated linoleic acid, conjugated linoleic acid triglyceride.
8. fullerene as claimed in claim 3 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that described edible Emulsifier is A or the mixture of A and B;Wherein A is oligomeric maltose, maltodextrin, corn syrup solid, oligofructose, resists 1 kind or 2 kinds in property dextrin, skimmed milk power;B is casein sodium, list, diglycerine fatty acid ester, octenyl succinic acid starch Sodium, ascorbic acid, sodium ascorbate, gelatin, polydextrose, phosphatide, natural VE, sodium tripolyphosphate, Arabic gum and anti- One kind in bad hematic acid palmitate;
Optional, the wall material is soybean protein isolate, xanthans, converted starch, gelatin, carboxymethyl cellulose, maltodextrin In 2 kinds or 3 kinds or more mix.
9. fullerene as described in claim 1 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that the micro-capsule The preparation method of powder is,
It is prepared by oil phase:Nutrition compounding oil is prepared by fatty acid proportion, is dissolved into after then fullerene sterilizes in nutrition compounding oil, At the oily compound of compounding;Food emulsifier is dissolved into the oily compound of compounding, oil phase is obtained;
It is prepared by water phase:Wall material is dissolved in 60-80 DEG C of hot water and obtains water phase;Preferably, the temperature of hot water is 60-80 DEG C;
Mixing sterilizing:Gained water phase is mixed evenly with oil phase, is then sterilized;
Homogeneous, spraying, drying:Homogeneous sprays, is dried to obtain fullerene microcapsule powder.
10. fullerene as described in claim 1 be used to be prepared into the purposes of fullerene microcapsule powder, which is characterized in that described micro- Capsule powder have improve oxidation resistance, and/or improve immunity, and/or can pre- anti-cancer, delay neurodegenerative disease, and/or The purposes relieved the effect of alcohol.
CN201810259287.8A 2018-03-27 2018-03-27 Fullerene be used to be prepared into the purposes of fullerene microcapsule powder Pending CN108497099A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN201810259287.8A CN108497099A (en) 2018-03-27 2018-03-27 Fullerene be used to be prepared into the purposes of fullerene microcapsule powder
CN201811123023.6A CN110301483A (en) 2018-03-27 2018-09-26 The purposes of fullerene compound and fullerene microcapsule powder and its preparation method and application
CN201811365406.4A CN109258931A (en) 2018-03-27 2018-11-16 Fullerene additive for farm animal feed and preparation method thereof and feed
CN201811365697.7A CN109258932A (en) 2018-03-27 2018-11-16 Fullerene feed for pet additive and preparation method thereof and feed
CN201811365700.5A CN109258934A (en) 2018-03-27 2018-11-16 Application of the fullerene microcapsule powder as feed addictive
CN202210449776.6A CN115024365A (en) 2018-03-27 2018-11-16 Application of fullerene to preparation of fullerene microcapsule powder and preparation method
CN201811365699.6A CN109258933A (en) 2018-03-27 2018-11-16 Fullerene feeding additive aquatic animal and preparation method thereof and feed
PCT/CN2018/118812 WO2019184419A1 (en) 2018-03-27 2018-12-03 Use of fullerene compound, fullerene microcapsule powder and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810259287.8A CN108497099A (en) 2018-03-27 2018-03-27 Fullerene be used to be prepared into the purposes of fullerene microcapsule powder

Publications (1)

Publication Number Publication Date
CN108497099A true CN108497099A (en) 2018-09-07

Family

ID=63378685

Family Applications (7)

Application Number Title Priority Date Filing Date
CN201810259287.8A Pending CN108497099A (en) 2018-03-27 2018-03-27 Fullerene be used to be prepared into the purposes of fullerene microcapsule powder
CN201811123023.6A Pending CN110301483A (en) 2018-03-27 2018-09-26 The purposes of fullerene compound and fullerene microcapsule powder and its preparation method and application
CN201811365406.4A Pending CN109258931A (en) 2018-03-27 2018-11-16 Fullerene additive for farm animal feed and preparation method thereof and feed
CN201811365697.7A Pending CN109258932A (en) 2018-03-27 2018-11-16 Fullerene feed for pet additive and preparation method thereof and feed
CN201811365699.6A Pending CN109258933A (en) 2018-03-27 2018-11-16 Fullerene feeding additive aquatic animal and preparation method thereof and feed
CN201811365700.5A Pending CN109258934A (en) 2018-03-27 2018-11-16 Application of the fullerene microcapsule powder as feed addictive
CN202210449776.6A Pending CN115024365A (en) 2018-03-27 2018-11-16 Application of fullerene to preparation of fullerene microcapsule powder and preparation method

Family Applications After (6)

Application Number Title Priority Date Filing Date
CN201811123023.6A Pending CN110301483A (en) 2018-03-27 2018-09-26 The purposes of fullerene compound and fullerene microcapsule powder and its preparation method and application
CN201811365406.4A Pending CN109258931A (en) 2018-03-27 2018-11-16 Fullerene additive for farm animal feed and preparation method thereof and feed
CN201811365697.7A Pending CN109258932A (en) 2018-03-27 2018-11-16 Fullerene feed for pet additive and preparation method thereof and feed
CN201811365699.6A Pending CN109258933A (en) 2018-03-27 2018-11-16 Fullerene feeding additive aquatic animal and preparation method thereof and feed
CN201811365700.5A Pending CN109258934A (en) 2018-03-27 2018-11-16 Application of the fullerene microcapsule powder as feed addictive
CN202210449776.6A Pending CN115024365A (en) 2018-03-27 2018-11-16 Application of fullerene to preparation of fullerene microcapsule powder and preparation method

Country Status (1)

Country Link
CN (7) CN108497099A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109007840A (en) * 2018-09-18 2018-12-18 广东雪芝康生物科技有限公司 A kind of nutritive plant powder and preparation method thereof by adjusting gene reducing weight and blood fat
CN109258931A (en) * 2018-03-27 2019-01-25 厦门福慈生物科技有限公司 Fullerene additive for farm animal feed and preparation method thereof and feed
CN109288058A (en) * 2018-12-05 2019-02-01 北京富乐喜科技有限公司 A kind of active health-care preparation of fullerene enhancing normal cell and preparation method
CN109430873A (en) * 2018-11-26 2019-03-08 荣海生物科技有限公司 A kind of anti-oxidant linseed oil microcapsules and preparation method thereof
CN109453136A (en) * 2018-11-14 2019-03-12 山东大学 A kind of antioxygen microcapsules and preparation method thereof containing fullerene
CN110150659A (en) * 2019-06-06 2019-08-23 齐向民 A kind of fullerene nano-health care nutrient solution
WO2019184419A1 (en) * 2018-03-27 2019-10-03 厦门福慈生物科技有限公司 Use of fullerene compound, fullerene microcapsule powder and preparation method and application thereof
CN111228306A (en) * 2020-03-06 2020-06-05 厦门福纳新材料科技有限公司 Application of fullerene and fullerene derivative in regulating intestinal flora
CN112956686A (en) * 2021-03-17 2021-06-15 厦门福慈生物科技有限公司 Bowel relaxing composition and preparation method thereof
CN113456673A (en) * 2021-07-19 2021-10-01 厦门福纳新材料科技有限公司 Medicine for treating ulcerative colitis and application of fullerene as active component
US20210378982A1 (en) * 2018-09-24 2021-12-09 The Cleveland Clinic Foundation Fullerenes to treat diseases and conditions

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109845905A (en) * 2019-03-27 2019-06-07 张振芳 A kind of pig growth feed and preparation method thereof comprising fullerene derivate
CN109805194A (en) * 2019-03-28 2019-05-28 东北农业大学 A kind of compound emulsifying agent of animal feed, application method and application
CN110710613A (en) * 2019-11-21 2020-01-21 何祥 Mixed plant sterol feed additive and preparation method thereof
CN110917137B (en) * 2019-11-26 2021-08-10 江南大学 Preparation method of Pickering emulsion with synergistic and stable prolamin nanoparticles and starch nanoparticles
CN111265547A (en) * 2020-02-26 2020-06-12 上海紫河生物科技有限公司 Fullerene and fullerene derivative-containing disinfection spray and preparation method thereof
CN111345408B (en) * 2020-03-20 2023-05-23 广州市优百特饲料科技有限公司 Special emulsifier for aquatic animals and preparation method and application method thereof
US11224574B1 (en) * 2020-08-06 2022-01-18 Valvet Kcare Gel-inducible composition for pet administration assistance
CN112244279A (en) * 2020-09-25 2021-01-22 东南大学 Fullerene solid self-emulsifying material and preparation method and application thereof
CN114431351A (en) * 2020-11-03 2022-05-06 河北科星药业有限公司 Nutritional paste for sterilizing dogs and cats and preparation method thereof
CN113662051B (en) * 2021-08-23 2023-12-12 山西农业大学山西功能食品研究院 Linseed oil and hemp seed oil blended blend oil and preparation method thereof
CN114176157A (en) * 2021-11-15 2022-03-15 安佑生物科技集团股份有限公司 Green additive for inhibiting coccidiosis of livestock and poultry, preparation method and application
CN114948762A (en) * 2021-12-31 2022-08-30 北京福纳康生物技术有限公司 Fullerene powder material and preparation method and application thereof
CN114468167A (en) * 2022-03-14 2022-05-13 中国科学院亚热带农业生态研究所 Feed additive for improving growth performance of live pigs as well as preparation method and application of feed additive
CN114601039A (en) * 2022-03-16 2022-06-10 江苏省农业科学院 Method for improving oestrus rate and conception rate of sheep under heat stress
CN114847418B (en) * 2022-05-24 2023-08-22 华南农业大学 Composite fat source for improving muscle quality of tilapia based on accurate nutrition requirement of fatty acid
CN115736221A (en) * 2022-12-06 2023-03-07 洽洽食品股份有限公司 Multilayer microencapsulated nut powder and production process thereof
CN117461737B (en) * 2023-12-05 2024-05-03 山东晟迅康生物科技有限公司 Feed additive for reducing nutrition loss and preparation method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003310810A (en) * 2002-04-25 2003-11-05 Sato Seisakusho:Kk Golf tee
JP2003310180A (en) * 2002-04-30 2003-11-05 Miura Co Ltd Food
WO2005105214A1 (en) * 2004-05-04 2005-11-10 Universite Paris Sud Compositions comprising water-insoluble fullerenes and their use for preventing damages caused by free radicals
TN2011000327A1 (en) * 2011-06-30 2012-12-17 Fathi Moussa Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals
CN102696923B (en) * 2012-06-15 2014-02-12 天津昌农科技有限责任公司 Premix compound for aquatic products, application thereof in feed additive, and batch thereof
CN102987382A (en) * 2012-08-08 2013-03-27 辽宁省大连海洋渔业集团公司 Krill oil microcapsule powder and preparation method thereof
US9682150B1 (en) * 2013-10-04 2017-06-20 NextGen Research Anti-aging nutritional supplement compositions for animals
CN103705388A (en) * 2013-12-19 2014-04-09 深圳市通产丽星股份有限公司 Fullerene capsule and application thereof
CN106509161A (en) * 2016-10-24 2017-03-22 厦门福慈生物科技有限公司 Oxidation resistant edible oil and preparation method thereof
CN106491644A (en) * 2016-11-25 2017-03-15 北京福纳康生物技术有限公司 A kind of fullerene soft capsule and preparation method
CN107048405A (en) * 2017-03-03 2017-08-18 武汉锶博睿医药技术有限公司 Aliphatic acid component microcapsules and preparation method thereof
CN107412190A (en) * 2017-09-19 2017-12-01 太仓市林港农场专业合作社 A kind of allicin compound microcapsule and preparation method thereof
CN108497099A (en) * 2018-03-27 2018-09-07 厦门福慈生物科技有限公司 Fullerene be used to be prepared into the purposes of fullerene microcapsule powder

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019184419A1 (en) * 2018-03-27 2019-10-03 厦门福慈生物科技有限公司 Use of fullerene compound, fullerene microcapsule powder and preparation method and application thereof
CN109258931A (en) * 2018-03-27 2019-01-25 厦门福慈生物科技有限公司 Fullerene additive for farm animal feed and preparation method thereof and feed
CN109258933A (en) * 2018-03-27 2019-01-25 厦门福慈生物科技有限公司 Fullerene feeding additive aquatic animal and preparation method thereof and feed
CN109258932A (en) * 2018-03-27 2019-01-25 厦门福慈生物科技有限公司 Fullerene feed for pet additive and preparation method thereof and feed
CN109258934A (en) * 2018-03-27 2019-01-25 厦门福慈生物科技有限公司 Application of the fullerene microcapsule powder as feed addictive
CN110301483A (en) * 2018-03-27 2019-10-08 厦门福慈生物科技有限公司 The purposes of fullerene compound and fullerene microcapsule powder and its preparation method and application
CN109007840A (en) * 2018-09-18 2018-12-18 广东雪芝康生物科技有限公司 A kind of nutritive plant powder and preparation method thereof by adjusting gene reducing weight and blood fat
US20210378982A1 (en) * 2018-09-24 2021-12-09 The Cleveland Clinic Foundation Fullerenes to treat diseases and conditions
CN109453136B (en) * 2018-11-14 2021-01-05 山东大学 Antioxidant microcapsule containing fullerene and preparation method thereof
CN109453136A (en) * 2018-11-14 2019-03-12 山东大学 A kind of antioxygen microcapsules and preparation method thereof containing fullerene
CN109430873A (en) * 2018-11-26 2019-03-08 荣海生物科技有限公司 A kind of anti-oxidant linseed oil microcapsules and preparation method thereof
CN109288058A (en) * 2018-12-05 2019-02-01 北京富乐喜科技有限公司 A kind of active health-care preparation of fullerene enhancing normal cell and preparation method
CN110150659A (en) * 2019-06-06 2019-08-23 齐向民 A kind of fullerene nano-health care nutrient solution
CN111228306A (en) * 2020-03-06 2020-06-05 厦门福纳新材料科技有限公司 Application of fullerene and fullerene derivative in regulating intestinal flora
CN112956686A (en) * 2021-03-17 2021-06-15 厦门福慈生物科技有限公司 Bowel relaxing composition and preparation method thereof
CN113456673A (en) * 2021-07-19 2021-10-01 厦门福纳新材料科技有限公司 Medicine for treating ulcerative colitis and application of fullerene as active component

Also Published As

Publication number Publication date
CN109258931A (en) 2019-01-25
CN115024365A (en) 2022-09-09
CN110301483A (en) 2019-10-08
CN109258934A (en) 2019-01-25
CN109258932A (en) 2019-01-25
CN109258933A (en) 2019-01-25

Similar Documents

Publication Publication Date Title
CN108497099A (en) Fullerene be used to be prepared into the purposes of fullerene microcapsule powder
US6190680B1 (en) Oily composition and process for producing the same
CN108112762A (en) A kind of new type functional soft sweets and preparation method thereof
CN104822279A (en) Human milk oligosaccharides to ameliorate symptoms of stress
WO2019184419A1 (en) Use of fullerene compound, fullerene microcapsule powder and preparation method and application thereof
CN107319525A (en) One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof
CN104955344A (en) Nutritional compositions comprising neuroprotective dietary oligosaccharides
CN104004583B (en) Containing the natural health vegetables oil and its preparation method and application of linoleic acid plus linolenic acid
JP7458788B2 (en) Encapsulated nutritional and pharmaceutical compositions
CN104522318B (en) A kind of micro-capsule fat powder for improving the enrichment meat, eggs and milks of Ω 3 and preparation method thereof
CN107050438A (en) Beautiful-skin-promoagent agent and use thereof
TW201236578A (en) Nutritional products comprising beta-hydroxy-beta-methylbutyrate
CN106858595A (en) One kind burn tailored version clinical nutrition formula and preparation method thereof
CN107373508A (en) A kind of fatty powder for control body weight and preparation method thereof
CN109123660A (en) A kind of walnut lactalbumin composite powder and preparation method thereof for maternal nutritional product
CN108308597A (en) A kind of malnutrition tailored version clinical nutrition formula and preparation method thereof
AU2020102282A4 (en) Immunity-boosting gel candy for children and the method of preparation
CN111743996A (en) Oral emulsion for improving memory and senile dementia and preparation method thereof
JP4634757B2 (en) Emulsified liquid enteral nutrient
JP2022065087A (en) Preparation and stabilization methods for emulsion having omega-3 by isometric crystal network of cellulose derivative
JP2019135217A (en) Powder composition, method for producing powder composition, dry eye improving agent, skin quality improving agent, food and drink, cosmetic, and pet food
CN106937731A (en) Queen bee nit powder extracts and its preparation method and application
CN112655802A (en) Calcium gel candy and preparation process thereof
CN111000240A (en) Eucommia seed oil microcapsule powder, preparation method and application
RU2602608C1 (en) Functional food products and method for production thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180907

WD01 Invention patent application deemed withdrawn after publication